An oral immunotherapy designed to treat dust mite allergy, made by Denmark's ALK-Abello, could soon become an option for thousands of people seeking treatment for persistent symptoms through the NHS.

An 86-year-old man was evaluated for chronic cough and right lower lobe (RLL) mass. His medical history was significant for severe chronic obstructive lung disease (COPD). He had smoked one pack of ...